Last reviewed · How we verify
losartan / Duration of Treatment: 6 weeks — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
losartan / Duration of Treatment: 6 weeks (losartan / Duration of Treatment: 6 weeks) — Organon and Co.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| losartan / Duration of Treatment: 6 weeks TARGET | losartan / Duration of Treatment: 6 weeks | Organon and Co | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- losartan / Duration of Treatment: 6 weeks CI watch — RSS
- losartan / Duration of Treatment: 6 weeks CI watch — Atom
- losartan / Duration of Treatment: 6 weeks CI watch — JSON
- losartan / Duration of Treatment: 6 weeks alone — RSS
Cite this brief
Drug Landscape (2026). losartan / Duration of Treatment: 6 weeks — Competitive Intelligence Brief. https://druglandscape.com/ci/losartan-duration-of-treatment-6-weeks. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab